{"id":"https://openalex.org/W4361967418","doi":"https://doi.org/10.1158/1078-0432.22473654.v1","title":"Supplementary Figures from A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma","display_name":"Supplementary Figures from A Phase I/II Trial of Cetuximab in Combination with Interleukin-12 Administered to Patients with Unresectable Primary or Recurrent Head and Neck Squamous Cell Carcinoma","publication_year":2023,"publication_date":"2023-03-31","ids":{"openalex":"https://openalex.org/W4361967418","doi":"https://doi.org/10.1158/1078-0432.22473654.v1"},"language":"en","primary_location":{"id":"doi:10.1158/1078-0432.22473654.v1","doi":"https://doi.org/10.1158/1078-0432.22473654.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22473654.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"volume":null,"type":"supplementary-materials","indexed_in":["crossref"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://doi.org/10.1158/1078-0432.22473654.v1","any_repository_has_fulltext":null},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5028975540","display_name":"Elizabeth L. McMichael","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Elizabeth L. McMichael","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073968481","display_name":"Brooke N. Benner","orcid":"https://orcid.org/0000-0001-7471-6886","observed_orcids":["https://orcid.org/0000-0001-7471-6886"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Brooke Benner","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033505983","display_name":"Lakhvir S. Atwal","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Lakhvir S. Atwal","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083608306","display_name":"Nicholas B. Courtney","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Nicholas B. Courtney","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015153331","display_name":"Xiaokui Molly Mo","orcid":"https://orcid.org/0000-0002-9797-2687","observed_orcids":["https://orcid.org/0000-0002-9797-2687"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Xiaokui Mo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082352583","display_name":"Melanie E. Davis","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melanie E. Davis","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5102890276","display_name":"Amanda R. Campbell","orcid":"https://orcid.org/0000-0002-0359-3900","observed_orcids":["https://orcid.org/0000-0002-0359-3900"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Amanda R. Campbell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080361449","display_name":"Megan Christina Duggan","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Megan C. Duggan","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053484014","display_name":"Kallan Williams","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kallan Williams","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5056489446","display_name":"Kyle A. Martin","orcid":"https://orcid.org/0000-0001-7402-9306","observed_orcids":["https://orcid.org/0000-0001-7402-9306"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kyle Martin","raw_affiliation_strings":[],"raw_orcid":"https://orcid.org/0000-0001-7402-9306","affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054983553","display_name":"Kala M. Levine","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Kala Levine","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5024285638","display_name":"Gonzalo N. Olaverria Salavaggione","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Gonzalo N. Olaverria Salavaggione","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079526097","display_name":"Tiffany C. Noel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Tiffany Noel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5005521067","display_name":"Akaansha Ganju","orcid":"https://orcid.org/0000-0003-0395-9287","observed_orcids":["https://orcid.org/0000-0003-0395-9287"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Akaansha Ganju","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5054522457","display_name":"Sarvani Uppati","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sarvani Uppati","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006315280","display_name":"Bonnie K. Paul","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Bonnie Paul","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063621818","display_name":"Thomas E. Olencki","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Thomas Olencki","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112408130","display_name":"Theodoros Nicholas Teknos","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Theodoros N. Teknos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Panos Savvides","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Panos Savvides","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5050245185","display_name":"Susheela Tridandapani","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Susheela Tridandapani","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000921376","display_name":"John C. Byrd","orcid":"https://orcid.org/0000-0001-9830-0711","observed_orcids":["https://orcid.org/0000-0001-9830-0711"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"John C. Byrd","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049192022","display_name":"Michael A. Caligiuri","orcid":"https://orcid.org/0000-0002-4095-3020","observed_orcids":["https://orcid.org/0000-0002-4095-3020"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Michael A. Caligiuri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5043871151","display_name":"Stephen V. Liu","orcid":"https://orcid.org/0000-0002-4852-3914","observed_orcids":["https://orcid.org/0000-0002-4852-3914"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Stephen V. Liu","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5060897770","display_name":"William Edgar Carson","orcid":"https://orcid.org/0000-0001-7024-7533","observed_orcids":["https://orcid.org/0000-0001-7024-7533"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"William E. Carson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10307","display_name":"Head and Neck Cancer Studies","score":0.9940999746322632,"subfield":{"id":"https://openalex.org/subfields/2733","display_name":"Otorhinolaryngology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0026000000070780516,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11306","display_name":"Nonmelanoma Skin Cancer Studies","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9990000128746033},{"id":"https://openalex.org/keywords/il-12","display_name":"IL-12","score":1.0},{"id":"https://openalex.org/keywords/head-and-neck-squamous-cell-carcinoma","display_name":"head and neck squamous cell carcinoma","score":0.9990000128746033},{"id":"https://openalex.org/keywords/recurrent-cancer","display_name":"recurrent cancer","score":0.6759999990463257},{"id":"https://openalex.org/keywords/serum-cytokines","display_name":"serum cytokines","score":0.8980000019073486},{"id":"https://openalex.org/keywords/interferon-gamma","display_name":"interferon-gamma","score":0.7089999914169312},{"id":"https://openalex.org/keywords/cxcl10","display_name":"CXCL10","score":0.9629999995231628},{"id":"https://openalex.org/keywords/tnf-alpha","display_name":"TNF-\u03b1","score":0.9150000214576721},{"id":"https://openalex.org/keywords/mip-1alpha","display_name":"MIP-1\u03b1","score":0.9169999957084656},{"id":"https://openalex.org/keywords/mip-1beta","display_name":"MIP-1\u03b2","score":0.9810000061988831},{"id":"https://openalex.org/keywords/ccl5","display_name":"RANTES","score":0.9990000128746033},{"id":"https://openalex.org/keywords/gm-csf","display_name":"GM-CSF","score":0.9959999918937683},{"id":"https://openalex.org/keywords/interleukin-8","display_name":"interleukin-8","score":0.9959999918937683},{"id":"https://openalex.org/keywords/myeloid-derived-suppressor-cells","display_name":"myeloid-derived suppressor cells","score":0.8420000076293945},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.7260000109672546},{"id":"https://openalex.org/keywords/immune-checkpoint-inhibitor-combination-therapy","display_name":"immune checkpoint inhibitor combination","score":0.39100000262260437}],"concepts":[{"id":"https://openalex.org/C2778513237","wikidata":"https://www.wikidata.org/wiki/Q419553","display_name":"CD14","level":3,"score":0.6892287731170654},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6762454509735107},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.49316591024398804},{"id":"https://openalex.org/C2779998722","wikidata":"https://www.wikidata.org/wiki/Q420296","display_name":"Cetuximab","level":4,"score":0.4906233847141266},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4827796518802643},{"id":"https://openalex.org/C2776833033","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck squamous-cell carcinoma","level":4,"score":0.46155568957328796},{"id":"https://openalex.org/C176290653","wikidata":"https://www.wikidata.org/wiki/Q21114013","display_name":"CD33","level":4,"score":0.438848614692688},{"id":"https://openalex.org/C2776804306","wikidata":"https://www.wikidata.org/wiki/Q3959958","display_name":"CD15","level":4,"score":0.4375620186328888},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.3625461459159851},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3475029468536377},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.26030170917510986},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.24753311276435852},{"id":"https://openalex.org/C2776530083","wikidata":"https://www.wikidata.org/wiki/Q1783924","display_name":"Head and neck cancer","level":3,"score":0.18336233496665955},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.17694157361984253},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.14559456706047058},{"id":"https://openalex.org/C542903549","wikidata":"https://www.wikidata.org/wiki/Q422248","display_name":"Monoclonal antibody","level":3,"score":0.08049416542053223},{"id":"https://openalex.org/C10205521","wikidata":"https://www.wikidata.org/wiki/Q4035578","display_name":"CD34","level":3,"score":0.0},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.0},{"id":"https://openalex.org/C28328180","wikidata":"https://www.wikidata.org/wiki/Q48196","display_name":"Stem cell","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1078-0432.22473654.v1","doi":"https://doi.org/10.1158/1078-0432.22473654.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22473654.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"}],"best_oa_location":{"id":"doi:10.1158/1078-0432.22473654.v1","doi":"https://doi.org/10.1158/1078-0432.22473654.v1","is_oa":true,"landing_page_url":"https://doi.org/10.1158/1078-0432.22473654.v1","pdf_url":null,"source":null,"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"acceptedVersion","is_accepted":true,"is_published":false,"raw_source_name":"American Association for Cancer Research","raw_type":"posted-content"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":0.9789000153541565,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2800301898","https://openalex.org/W2947405510","https://openalex.org/W4361959331","https://openalex.org/W2383106189","https://openalex.org/W3212266918","https://openalex.org/W4362400407","https://openalex.org/W4390694595","https://openalex.org/W2884212831","https://openalex.org/W7161405884","https://openalex.org/W2359651749"],"abstract_inverted_index":{"Supplemental":[0,74,144],"Figure":[1,75,145],"S1.":[2],"Levels":[3,77],"of":[4,12,16,78,86,91,156],"serum":[5,79],"cytokines":[6,18,80,93],"in":[7,53,81,122,210],"patients":[8,82],"over":[9],"the":[10,17,56,92,125],"course":[11],"treatment.":[13],"Serum":[14,89],"levels":[15,90],"IFN-\u03b3":[19],"(A),":[20,95],"IP-10":[21],"(B),":[22,97],"TNF-\u03b1":[23,73],"(C)":[24],"MIP-1\u03b1":[25,94],"(D),":[26,101],"MIP-1\u03b2":[27,96],"(E),":[28],"RANTES":[29,98],"(F),":[30],"GM":[31],"CSF":[32],"(G),":[33],"and":[34,41,55,102,109,124,152,159,177,189,196],"IL-8":[35,103],"(H)":[36],"were":[37,105,170,183,199],"measured":[38,106],"at":[39,107],"baseline":[40,108],"during":[42,110],"cycle":[43,111],"8":[44,112],"using":[45,113],"a":[46,114],"custom":[47,115],"V-Plex":[48,116],"assay.":[49,117],"Assay":[50],"was":[51,58,120,127],"performed":[52,121],"triplicate":[54,123],"average":[57,126],"plotted":[59,128],"for":[60,66,69,72,129,149],"each":[61,130],"individual":[62,131],"patient.":[63],"*,":[64],"p=0.0008":[65],"IFN-\u03b3,":[67],"p=0.0011":[68],"IP-10,":[70],"p=0.0102":[71],"S2.":[76],"stratified":[83,133],"by":[84,134,186,202],"length":[85],"progression-free":[87,135],"survival.":[88],"(C),":[99],"GM-CSF":[100],"(E)":[104],"The":[118],"assay":[119],"patient":[132],"survival":[136],"greater":[137],"than":[138,141],"or":[139],"less":[140],"100":[142],"days":[143],"S3.":[146,212],"Gating":[147],"strategy":[148],"defining":[150],"monocytic":[151],"granulocytic":[153],"MDSC.":[154,163],"Examples":[155],"monocytic-dominant":[157],"(A)":[158],"granulocytic-dominant":[160],"(B)":[161],"total":[162,203],"PBMCs":[164],"procured":[165],"from":[166,194],"pre-therapy":[167],"blood":[168],"draws":[169],"stained":[171],"with":[172],"anti-CD33-APC,":[173],"anti-HLA-DR-PECy7,":[174],"anti-CD11b-PE,":[175],"anti-CD14-V-450,":[176],"anti":[178],"CD15-FITC":[179],"antibodies;":[180],"CD33+/HLA-DR-":[181],"populations":[182],"further":[184],"characterized":[185],"CD15,":[187],"CD14,":[188],"CD11b":[190],"expression.":[191],"Percentages":[192],"gleaned":[193],"CD15+CD11b+":[195],"CD14+CD11b+":[197],"quadrants":[198],"back":[200],"multiplied":[201],"MDSC":[204],"(CD33+HLA-DR-)":[205],"to":[206],"obtain":[207],"values":[208],"presented":[209],"Table":[211]},"counts_by_year":[],"updated_date":"2026-09-26T08:19:03.415552","created_date":"2023-04-05T00:00:00"}